APA način citiranja

Bridges, K. A., Chen, X., Liu, H., Rock, C., Buchholz, T. A., Shumway, S. D., . . . Meyn, R. E. (2016). MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells. Oncotarget.

Čikaški stil citiranja

Bridges, Kathleen A., Xingxing Chen, Huifeng Liu, Crosby Rock, Thomas A. Buchholz, Stuart D. Shumway, Heath D. Skinner, i Raymond E. Meyn. "MK-8776, a Novel Chk1 Kinase Inhibitor, Radiosensitizes P53-defective Human Tumor Cells." Oncotarget 2016.

MLA način citiranja

Bridges, Kathleen A., et al. "MK-8776, a Novel Chk1 Kinase Inhibitor, Radiosensitizes P53-defective Human Tumor Cells." Oncotarget 2016.